28th Mar 2006 16:28
Allergy Therapeutics PLC28 March 2006 Allergy Therapeutics plc ("the Company") The Company received notification on 27 March 2006 that Fidelity InternationalLimited ("FIL") and its direct and indirect subsidiaries, including FidelityInvestment Services Ltd ("FISL"), Fidelity Gestion (FIGEST), FidelityInvestments Advisory (Korea) Limited (FIA(K)L), Fidelity Investments Management(Hong Kong) Limited (FIMHK), Fidelity Pension Management ("FPM") and FidelityInvestments International (FII), investment managers for various non-USinvestment companies and institutional clients, are together interested in atotal of 9,442,594 ordinary shares in the Company, representing approximately14.99 per cent. of the Company's issued share capital. This shareholding is registered as follows: Shares held Management Company Nominee/Registered Name 1,478,900 FPM Northern Trust London 663,500 FPM Mellon Bank 611,100 FPM JP Morgan, Bournemouth 484,600 FPM Bank of New York Brussels 457,784 FPM State Str Bk and Tr Co Lndn 317,700 FPM Bankers Trust London 150,100 FPM Midland Securities Services 80,200 FPM Clydesdale Bank plc 3,812,798 FISL JP Morgan, Bournemouth 646,000 FIL Brown Bros Harrimn Ltd Lux 155,400 FIL Bank of New York Brussels 584,512 FIL JP Morgan, Bournemouth 9,442,594 Total holding This notifiable interest also comprises the notifiable interest of Mr Edward C.Johnson III, a principal shareholder of Fidelity International Limited, andinterests held on behalf of authorised unit trust schemes in the United Kingdom. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.